Network-1 Technologies, Inc 8-K, filed May 16, 2023
Network-1 Technologies, Inc. (NTIP)
About this 8-K
Network-1 Technologies, Inc filed this 8-K on May 16, 2023, reporting on events of May 12, 2023.
Items reported
- Item 2.02: Financial results
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of
earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or Other Jurisdiction | (Commission | (I.R.S. Employer |
| of Incorporation) | File Number) | Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 2.02 | Results of Operations and Financial Condition. |
On May 12, 2023, Network-1 Technologies, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2023. A copy of the press release is attached hereto as Exhibit 99.1.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit No. |
Description | |
| 99.1 | ||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
| -2- |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NETWORK-1 TECHNOLOGIES, INC. | ||
| Dated: May 16, 2023 | By: | /s/ Corey M. Horowitz |
Name: Corey M. Horowitz Title: Chairman and Chief Executive Officer |
||
-3-
Exhibit 99.1
FOR IMMEDIATE RELEASE
Corey M. Horowitz, Chairman and CEO
Network-1 Technologies, Inc.
203-920-1055
NETWORK-1 REPORTS FIRST QUARTER 2023 RESULTS
New Canaan, Connecticut – May 12, 2023 – Network-1 Technologies, Inc. (NYSE American: NTIP), a company engaged in the acquisition, development, licensing, and monetization of intellectual property assets, today announced financial results for the quarter ended March 31, 2023.
Network-1 had revenue of $537,000 for the three months ended March 31, 2023, as compared to no revenue for the three months ended March 31, 2022. The revenue of $537,000 for the three months ended March 31, 2023 was from the settlement of several lawsuits concerning Network-1’s Remote Power Patent.
Network-1 reported a net loss of $623,000 or $0.03 per share basic and diluted for the three months ended March 31, 2023 compared with a net loss of $1,312,000 or $0.05 per share basic and diluted for the three months ended March 31, 2022.
At March 31, 2023, Network-1’s principal sources of liquidity consisted of cash and cash equivalents and marketable securities of $46,839,000 and working capital of $45,902,000. Network-1 believes based on its current cash position that it will have sufficient cash to fund its operations for the foreseeable future.
To date, Network-1 has invested an aggregate of $7,000,000 in ILiAD Biotechnologies, LLC, a privately held clinical stage biotechnology company dedicated to the prevention of human disease caused by Bordetella pertussis. On March 10, 2023, ILiAD announced a peer reviewed publication in The Lancet, which summarized its adult Phase 2b clinical study of BPZE1, its proprietary intranasal vaccine for the prevention of pertussis. At March 31, 2023, Network-1 owned approximately 6.8% of the outstanding units of ILiAD on a non-fully diluted basis.
Since the inception of Network-1’s Share Repurchase Program through March 31, 2023, Network-1 has repurchased an aggregate of 9,349,449 shares of its common stock at an aggregate cost of $18,060,296 (exclusive of commissions) or an average per share price of $1.93. Network-1 repurchased 136,785 shares of its common stock during the three months ended March 31, 2023 at an aggregate cost of $302,202, or an average per share price of $2.21. At March 31, 2023, the dollar value of remaining shares that may be repurchased under the Share Repurchase Program was $3,095,688.
Network-1 continues to pay dividends consistent with its dividend policy which consists of semi-annual cash dividends of $0.05 per share ($0.10 per share annually) which are anticipated to be paid in March and September of each year. On March 3, 2023, Network-1’s Board of Directors declared a semi-annual cash dividend of $0.05 per share which was paid on March 31, 2023 to all shareholders of record as of March 15, 2023. Network-1’s dividend policy undergoes a periodic review by the Board of Directors and is subject to change at any time depending upon Network-1’s earnings, financial requirements and other factors existing at the time.
ABOUT NETWORK-1 TECHNOLOGIES, INC.
Network-1 Technologies, Inc. is engaged in the development, licensing and protection of its intellectual property and proprietary technologies. Network-1 works with inventors and patent owners to assist in the development and monetization of their patented technologies. Network-1 currently owns ninety-seven (97) U.S. patents and eight (8) international patents covering various telecommunications and data networking technologies as well as technologies relating to document stream operating systems and the identification of media content. Network-1’s current strategy includes efforts to monetize five patent portfolios (the Cox, M2M/IoT, HFT, Mirror Worlds and Remote Power Patent portfolios). Network-1’s strategy is to focus on acquiring and investing in high quality patents which management believes have the potential to generate significant licensing opportunities as Network-1 has achieved with respect to its Remote Power Patent and Mirror Worlds Patent Portfolio. Network-1’s Remote Power Patent has generated licensing revenue in excess of $187,000,000 from May 2007 through March 31, 2023. Network-1 has achieved licensing and other revenue of $47,150,000 through March 31, 2023 with respect to its Mirror Worlds Patent Portfolio.
This release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements address future events and conditions concerning Network-1's business plans. Such statements are subject to a number of risk factors and uncertainties as disclosed in the Network-1's Annual Report on Form 10-K for the year ended December 31, 2022 and its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 filed with the Securities and Exchange Commission including, among others, Network-1’s uncertain revenue from licensing its intellectual property, uncertainty as to the outcome of pending litigation involving Network-1’s Cox Patent Portfolio and Remote Power Patent, whether Network-1 will be successful in its appeal to the Federal Circuit of the District Court judgement of non-infringement dismissing Network-1’s litigation against Facebook (now Meta Platforms, Inc.), the ability of Network-1 to successfully execute its strategy to acquire or make investments in high quality patents with significant licensing opportunities, Network-1's ability to achieve revenue and profits from its Cox Patent Portfolio, M2M/IoT Patent Portfolio, HFT Patent Portfolio and additional revenue and profit from its Mirror Worlds Patent Portfolio and Remote Power Patent as well as a return on its investment in ILiAD Biotechnologies, LLC or other intellectual property it may acquire or finance in the future, the ability of Network-1 to enter into additional license agreements, uncertainty as to whether cash dividends will continue be paid, Network-1's ability to enter into strategic relationships with third parties to license or otherwise monetize their intellectual property, the risk in the future of Network-1 being classified as a Personal Holding Company which may result in Network-1 issuing a special cash dividend to its stockholders, future economic conditions and technology changes and legislative, regulatory and competitive developments. Except as otherwise required to be disclosed in periodic reports, Network-1 expressly disclaims any future obligation or undertaking to update or revise any forward-looking statement contained herein.
The unaudited condensed consolidated statements of operations and comprehensive loss and unaudited condensed consolidated balance sheets are attached.
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)
| Three Months Ended March 31, | ||||||||
| 2023 | 2022 | |||||||
| REVENUE | $ | 537,000 | $ | — | ||||
| OPERATING EXPENSES: | ||||||||
| Costs of revenue | 151,000 | — | ||||||
| Professional fees and related costs | 298,000 | 250,000 | ||||||
| General and administrative | 781,000 | 572,000 | ||||||
| Amortization of patents | 83,000 | 75,000 | ||||||
| TOTAL OPERATING EXPENSES | 1,313,000 | 897,000 | ||||||
| OPERATING LOSS | (776,000 | ) | (897,000 | ) | ||||
| OTHER INCOME (LOSS) : | ||||||||
| Interest and dividend income, net | 310,000 | 80,000 | ||||||
| Net realized and unrealized gain (loss) on marketable securities | 364,000 | (514,000 | ) | |||||
| Total other income (loss), net | 674,000 | (434,000 | ) | |||||
| LOSS BEFORE INCOME TAXES AND EQUITY IN NET LOSSES OF EQUITY METHOD INVESTEE | (102,000 | ) | (1,331,000 | ) | ||||
| INCOME TAX PROVISION: | ||||||||
| Current | — | — | ||||||
| Deferred taxes, net | (153,000 | ) | (452,000 | ) | ||||
| Total income tax benefit | (153,000 | ) | (452,000 | ) | ||||
| INCOME (LOSS) BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE | $ | 51,000 | $ | (879,000 | ) | |||
| SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE | $ | (674,000 | ) | $ | (433,000 | ) | ||
| NET LOSS | $ | (623,000 | ) | $ | (1,312,000 | ) | ||
| Net loss per share: | ||||||||
| Basic | $ | (0.03 | ) | $ | (0.05 | ) | ||
| Diluted | $ | (0.03 | ) | $ | (0.05 | ) | ||
| Weighted average common shares outstanding: | ||||||||
| Basic | 23,866,821 | 23,909,115 | ||||||
| Diluted | 23,866,821 | 23,909,115 | ||||||
| Cash dividends declared per share | $ | 0.05 | $ | 0.05 | ||||
| NET LOSS | $ | (623,000 | ) | $ | (1,312,000 | ) | ||
| OTHER COMPREHENSIVE LOSS | ||||||||
| Net unrealized holding loss on corporate bonds and notes during the period, net of tax | — | (3,000 | ) | |||||
| COMPREHENSIVE LOSS | $ | (623,000 | ) | $ | (1,315,000 | ) | ||
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
March 31, 2023 | December 31, 2022 | |||||||
| ASSETS | ||||||||
| CURRENT ASSETS: | ||||||||
| Cash and cash equivalents | $ | 9,919,000 | $ | 13,448,000 | ||||
| Marketable securities, at fair value | 36,920,000 | 34,991,000 | ||||||
| Prepaid taxes | 177,000 | 177,000 | ||||||
| Other current assets | 119,000 | 348,000 | ||||||
| TOTAL CURRENT ASSETS | 47,135,000 | 48,964,000 | ||||||
| OTHER ASSETS: | ||||||||
| Patents, net of accumulated amortization | 1,509,000 | 1,592,000 | ||||||
| Equity investment | 6,578,000 | 7,252,000 | ||||||
| Operating leases right of - use asset | 145,000 | 161,000 | ||||||
| Security deposits | 13,000 | — | ||||||
| Total Other Assets | 8,245,000 | 9,005,000 | ||||||
| TOTAL ASSETS | $ | 55,380,000 | $ | 57,969,000 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY:
| ||||||||
| CURRENT LIABILITIES: | ||||||||
| Accounts payable | $ | 601,000 | $ | 507,000 | ||||
| Income taxes payable | 115,000 | 115,000 | ||||||
| Accrued contingency fees and related costs | 96,000 | — | ||||||
| Accrued payroll | 139,000 | 317,000 | ||||||
| Other accrued expenses | 203,000 | 587,000 | ||||||
| Operating lease obligation, current | 79,000 | 79,000 | ||||||
| Total Current Liabilities | 1,233,000 | 1,605,000 | ||||||
| LONG TERM LIABILITIES: | ||||||||
| Deferred tax liability | 1,008,000 | 1,161,000 | ||||||
| Operating lease obligation, non-current | 77,000 | 94,000 | ||||||
| TOTAL LIABILITIES | $ | 2,318,000 | $ | 2,860,000 | ||||
| COMMITMENTS AND CONTINGENCIES (Note G) | ||||||||
| STOCKHOLDERS’ EQUITY | ||||||||
| Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at March 31, 2023 and December 31, 2022 | — | — | ||||||
| Common stock, $0.01 par value; authorized 50,000,000 shares; 23,811,505 and 23,863,639 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively | 239,000 | 239,000 | ||||||
| Additional paid-in capital | 67,099,000 | 66,939,000 | ||||||
| Accumulated deficit | (14,262,000 | ) | (12,055,000 | ) | ||||
| Accumulated other comprehensive loss | (14,000 | ) | (14,000 | ) | ||||
| TOTAL STOCKHOLDERS’ EQUITY | 53,062,000 | 55,109,000 | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 55,380,000 | $ | 57,969,000 | ||||